Search Results - "Fernández‐Montalván, Amaury Ernesto"
-
1
BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling‐dependent tumor growth in mouse models
Published in International journal of cancer (15-01-2017)“…The PI3K‐AKT‐mTOR signaling cascade is activated in the majority of human cancers, and its activation also plays a key role in resistance to chemo and targeted…”
Get full text
Journal Article -
2
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor
Published in Journal of medicinal chemistry (14-11-2024)“…KAT6A and KAT6B genes are two closely related lysine acetyltransferases that transfer an acetyl group from acetyl coenzyme A (AcCoA) to lysine residues of…”
Get full text
Journal Article -
3
Abstract 4714: In vivo efficacy of BET inhibitor BAY 1238097 in preclinical models of melanoma and lung cancer
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Bromodomain and extra terminal domain (BET) family proteins which bind to acetylated lysines of histones and regulate gene transcription are promising targets…”
Get full text
Journal Article -
4
Abstract 4749: New benzazepine BET-inhibitors with improved oral bioavailability
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Bromodomain protein 4 (BRD4), a member of the bromodomain and extra-terminal domain (BET) protein family, binds to acetylated histone tails via its two…”
Get full text
Journal Article -
5
Abstract 4539: ATAD2 mediates DNA replication in cancer
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…ATAD2 (ATPase family AAA domain-containing protein 2) is an epigenetic regulator which associates with chromatin through its Bromodomain specialized in…”
Get full text
Journal Article